{"id":"NCT00289211","sponsor":"Shire","briefTitle":"C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks","officialTitle":"LEVP2005-1/Part A: A Double-blind, Placebo-Controlled, Clinical Study to Investigate the Efficacy and Safety of Purified C1 Esterase Inhibitor (Human) for the Treatment of HAE in Acute Attacks","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-03-14","primaryCompletion":"2007-04-13","completion":"2007-04-13","firstPosted":"2006-02-09","resultsPosted":"2010-06-02","lastUpdate":"2021-06-11"},"enrollment":83,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hereditary Angioedema"],"interventions":[{"type":"BIOLOGICAL","name":"C1 esterase inhibitor [human] (C1INH-nf)","otherNames":[]},{"type":"DRUG","name":"Placebo (saline)","otherNames":[]}],"arms":[{"label":"C1INH-nf","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The study objective was to determine the safety and efficacy of C1INH-nf for the treatment of acute HAE attacks.","primaryOutcome":{"measure":"Time to Beginning of Substantial Relief of the Defining Symptom","timeFrame":"Within 4 hours after initial treatment","effectByArm":[{"arm":"C1INH-nf","deltaMin":2,"sd":null},{"arm":"Placebo","deltaMin":4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.048"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":9},"locations":{"siteCount":37,"countries":["United States"]},"refs":{"pmids":["23312695","22856635","20818886"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":71},"commonTop":["Dermatitis contact","Injection site rash","Tetany"]}}